Regulus Therapeutics (RGLS) Announces Restructuring of Sanofi (SNY) Collaboration
November 6, 2018 7:40 AM
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
